Effects of psoroptes ovis infection and its control with an ivermectin controlled-release capsule on growing sheep. 1. Evaluation of weight gain, feed consumption and carcass value

Treatment strategies for sheep scab: An economic model of farmer behaviour

Ovine psoroptic mange (sheep scab) is a debilitating and damaging condition caused by a hypersensitivity reaction to the faecal material of the parasitic mite Psoroptes ovis. Farmers incur costs from the use of prophylactic acaricides and, if their sheep become infected, they incur the costs of therapeutic treatment plus the economic loss from reduced stock growth, lower reproductive rate, wool loss and hide damage. The unwillingness of farmers to use routine prophylactic treatment has been cited as a primary cause of the growing incidence of sheep scab in the United Kingdom (UK) since the disease was deregulated in 1992. However, if farmers behave rationally from an economic perspective, the optimum strategy that they should adopt will depend on the risk of infection and the relative costs of prophylactic versus therapeutic treatment, plus potential losses. This calculation is also complicated by the fact that the risk of infection is increased if neighbours have scab and reduced if neighbours treat prophylactically. Hence, for any farmer, the risk of infection and optimum approach to treatment is also contingent on the behaviour of neighbours, particularly when common grazing is used. Here, the relative economic costs of different prophylactic treatment strategies are calculated for upland and lowland farmers and a game theory model is used to evaluate the relative costs for a farmer and his/her neighbour under different risk scenarios. The analysis shows that prophylaxis with organophosphate (OP) dipping is a cost effective strategy, but only for upland farmers where the risk of infection is high. In all other circumstances prophylaxis is not cost effective relative to reliance on reactive (therapeutic) treatment. Hence, farmers adopting a reactive treatment policy only, are behaving in an economically rational manner. Prophylaxis and cooperation only become economically rational if the risk of scab infection is considerably higher than the current national average, or the cost of treatment is lower. Should policy makers wish to reduce the national prevalence of scab, economic incentives such as subsidising the cost of acaricides or rigorously applied financial penalties, would be required to make prophylactic treatment economically appealing to individual farmers. However, such options incur their own infrastructure and implementation costs for central government.

Costs of the major endemic diseases of sheep in Great Britain and the potential benefits of reduction in disease impact

The costs of three major endemic sheep diseases in Great Britain, gastro-intestinal (GI) parasites, footrot and scab, were estimated and compared with costs for other diseases from another study. Disease costs include lost performance, preventive measures and treatment of affected animals. The most costly disease, of those studied, for the British sheep industry is infestation with GI parasites, with estimated annual costs of £84 million. Annual costs for the other two diseases are £24 million for footrot and £8 million for sheep scab. This compares with literature estimates of £20 million for Chlamydial abortions and £12 million for toxoplasmosis. For sheep scab most costs are for preventive measures, therefore, short of eradication, a reduction in incidence will have a limited effect on costs. For GI parasites, costs are linearly related to the severity of the infestation and a reduction of the disease will have a proportional effect on the costs to the industry. For footrot about half the costs are for preventive measures, the other half is for lost production and treatment. A reduction in the incidence of footrot has a proportional effect on the £10 million associated with loss of production and treatment of infected animals. It is concluded that gastro-intestinal parasites and footrot are two sheep diseases in Britain for which a reduction of severity or incidence will have a large impact on costs of production.

Sarcoptic mange and metapodial development in growing male Iberian ibex (Capra pyrenaica)

The effect of mange (Sarcoptes scabiei) on metapodial growth was studied in 24 uninfested and 16 infested male Iberian ibex from Sierra Nevada National Park (southern Spain). Our results show that infested ibex had smaller metatarsal bones, lower body weight, and a delayed rhythm of ossification, by about 1 year. We conclude that skeletal development and body weight in the Iberian ibex are sensitive to sarcoptic mange.

A method for sheep scab control by applying selective treatment based on flock serology

Sheep scab, caused by Psoroptes ovis, is a severe and debilitating disease that can be treated and controlled by the use of acaricidal dips or the use of broad-spectrum avermectins. In Switzerland, control measures are state regulated. In particular, sheep should be routinely treated with ectocide dips or avermectin injections before they are moved onto common alpine pasture in late spring. However, a substantial part of the sheep population remains untreated and represents a potential reservoir for the mite population. Untreated sheep that are not moved to alpine pasture may infest treated sheep when flocks are reassembled in autumn. In an attempt to identify infested sheep, all flocks in the Canton of Schwyz (Switzerland) were serologically tested in 2001 and in 2002 (587 and 565 flocks, respectively). In 2003, a representative number (182 of the 531 flocks) was again investigated. Seropositive flocks were treated with doramectin (0.3 mg kg(-1) body weight, intramuscularly) from 2001 to 2003. In spring 2002, no chemo-methaphylaxis was given to seronegative flocks before movement onto common alpine pastures. Of the 587 flocks surveyed in spring 2001, 34 were seropositive (5.8%). These consisted of 21 infested with P. ovis, 1 with P. cuniculi, 4 with Chorioptes spp. and 8 of seropositivity of unknown origin; there was a decrease of seropositive flocks in spring 2002 (4.4%) with 15, 0, 2 and 8, respectively. Of the 182 flocks surveyed in spring 2003, just 4 flocks (2.2%) were seropositive. All the seropositive reactions in these flocks were the result of Chorioptes spp. infestations. There was a corresponding decrease in the proportion of seropositive animals from 6.3% in spring 2001 to 2.1% in spring 2003. These results corroborate the concept that it may be possible to target chemo-metaphylaxis and hence decrease the use of endectocides as well as of ectocides to control sheep scab. This would be of great benefit in reducing the likelihood of development of anthelmintic resistance against avermectins, decreasing the extent of environmental and human contamination with potentially toxic products and diminishing potential drug residues in meat and milk.

Chorioptic mange in dairy cattle: treatment with eprinomectin pour-on

A randomized block design study was conducted to confirm the efficacy of topical eprinomectin against naturally acquired Chorioptes bovis mite infestations. Twelve adult Simmentaler Fleckvieh cattle were formed into six replicates of two animals based on pretreatment mite counts. Within replicates, animals were randomly allocated to untreated controls or were treated with eprinomectin 0.5% pour-on solution at 1 mL/10 kg body weight (0.5 mg eprinomectin/kg body weight). Live mites were counted, and mange lesions were scored prior to treatment and at weekly intervals until the end of the study on day 56. Feed consumption was recorded daily throughout the study, and body weights were measured. Differences between variables were declared significant if p < or = 0.05. Mite counts for the cattle treated with eprinomectin were reduced by 100% from day 14 through the end of the study (p < 0.05). At each examination from day 21 through the end of the study, treated animals were significantly clinically improved as measured by lesion scoring compared with untreated controls. Weight gain and feed conversion efficiency were numerically higher in the eprinomectin-treated group. Results of this study demonstrate a positive response in growth rate following effective treatment of cattle for chorioptic mange and underline the economic importance of the parasite and the value of treatment.

Effects of Sarcoptic Mange and its Control with Oil of Cedrus deodara, Pongamia glabra, Jatropha curcas and Benzyl Benzoate, both with and without Ascorbic Acid on Growing Sheep: Assessment of Weight Gain, Liver Function, Nutrient Digestibility, Wool Production and Meat Quality

The aim of this study was to evaluate the therapeutic efficacy of commonly used acaricidal drugs in India and also to assess the effect of ascorbic acid as adjunct therapy in 72 growing sheep with sarcoptic mange, aged 5-6 months and weighing 20.4-31.7 kg. Eight replicates of nine animals were formed based on sex, and day 0 body weight. Drugs were applied locally on the affected parts daily and recovery changes in skin lesions were observed at the time of every application. L-ascorbic acid was administered intramuscularly. Skin scrapings were collected daily from each group and examined for the presence of mites. Body weights were measured every 10th day from day 0 to 60. Nutrient digestiblity was evaluated by studying digestibility coefficients for dry matter, crude protein, ether extract, crude fibre, nitrogen free extract, total carbohydrates and nutrient balance (nitrogen, calcium and phosphorus) for a 30-day period. The liver function was evaluated by bromosulphophthalein (BSP) dye retention time. The animals were shorn on day 60 post-treatment (PT). Meat quality assesment was carried out by killing sheep at 60 days PT and estimating pH, water-holding capacity (WHC), tenderness, muscle colour, rib eye area and fat thickness. The lambs treated with oil of Jatropha curcas ascorbic acid had significantly (P < 0.05) greater mean daily body weight gains (63.29 g) than the infected untreated control (41.10 g). This was also higher than the mean daily weight gain in other treated groups. Infected untreated sheep showed significantly (P < 0.01) reduced digestibility coefficients for dry matter, crude protein, crude fibre, ether extract and total carbohydrate, but no significant differences for nitrogen-free extract. Treated sheep had significantly higher positive nitrogen, calcium and phosphorus balances compared with infested untreated sheep. Oil of J. curcas plus ascorbic acid (OJC-AA) treated group was better over all other treated groups with respect to nutrient digestibility. The BSP test revealed significant (P < 0.05) increase in BSP retention time in sheep with sarcoptic mange. Post -treatment, the BSP retention time decreased in all treated groups and the decrease was maximum in OJC-AA treated group. The carcasses of sheep treated with OJC-AA had significantly (P < 0.01) higher water holding capacity, rib eye area and back fat thickness than the untreated infected control group. The muscle pH and tenderness values were significantly lower in OJC-AA treated group post-slaughter than infested untreated control group. Muscle colour of OJC-AA treated group was maximum bright red. The lambs treated with OJC-AA had significantly (P < 0.05) greater clean fleece weight and fleece yield than the untreated infected group. It is concluded that OJC was the better therapy for sarcoptic mange of sheep and ascorbic acid as adjunct therapy is advisable. OJC-AA therapy may be better from the point of view of improving two most important production parameters in sheep, that is, wool yield and meat production.

Productivity effects of bovine mange and control with ivermectin

A randomised block design study was conducted to evaluate the effects of mange on cattle. Twenty-four Simmentaler Fleckvieh bulls were formed into eight replicates of three bulls based on Day -56 body weight (288-414 kg). Within replicates bulls were randomly allocated to groups G1: uninfested control, G2: infested control or G3: infested, treated with 0.2mg ivermectin/kg (1% ivermectin injection; IVOMEC, Merial) on Day 0. The G2 and G3 bulls were infested with Sarcoptes/Chorioptes mites on Days -56 and -49. Feed consumption was recorded daily throughout the study (Days -56 to 56). Body weights were measured and serum samples collected. Mites were counted at bi-weekly intervals from Day -14 on. The carcasses of the bulls and the leather produced from their hides were evaluated. Differences between variables were declared significant if P</=0.05. All G2 and G3 bulls became infested. No Sarcoptes or Chorioptes mites were detected on the G3 bulls after Day 14 or Day 28, respectively, whereas G2 bulls maintained infestation throughout the study. From Days -42 to 0, anti-Sarcoptes antibody levels in the two infested groups increased linearly, while levels in the uninfested G1 remained near zero. From Day 14 to Day 56, antibody levels in G2 continued to increase and those in G3 decreased (P</=0.05). From Days -56 to 0, G1 had significantly greater mean weight gain (94.0 kg) than the infested G2 and G3 (76.1 and 75.9 kg). During Days 0-56, G3 gained significantly more weight (90.4 kg) than G2 (58.8 kg), while G1 gained 76.0 kg, not significantly different from either G2 or G3. During Days -56 to 0, the feed conversion efficiency (kg gain/kg feed) of the infested G2 and G3 was significantly lower than that of the uninfested G1; during the 56 days following treatment, feed conversion efficiency of G3 was significantly higher than that of G2, while the uninfested G1 was intermediate. Carcass weight of G2 was significantly lower than those of G1 and G3, which did not differ significantly. Carcass yield, rib eye area and weight of kidney fat of the uninfested G1 were significantly greater than those of G2 and G3. Weights of the adrenal glands, prescapular and precrural lymph nodes were significantly higher for the infested G2 than for the other two groups. Significantly less of leather area from the infested G2 was of usable quality than of the leathers from the uninfested G1 or the infested, treated G3, and the leathers from G2 showed significantly more severe gouging or etching than leathers from the two other groups.

Serological cross-sectional survey of psoroptic sheep scab in Switzerland

Sheep scab, caused by the mite Psoroptes ovis, is a notifiable disease in Switzerland. Mandatory prophylactic treatments are carried out in spring for all sheep grazing on common alpine pastures. Despite these strict control measures the number of outbreaks has been increasing in recent years, raising questions on the spread of this epizootic disease. To improve the traditional microscopic diagnosis, we developed an ELISA for the specific determination of antibodies against psoroptic antigens with sensitivity and specificity of 93.7 and 96.5%, respectively. Using this test, a serum bank, representative of the sheep population in Switzerland (approximately 15% of registered sheep flocks, randomly chosen, collected between February and May 1998), was screened. The prevalence using 16,404 sera was 10.4, and 11.9% of the 2083 flocks were diagnosed as positive. Additionally, there was a significant increase found for mean seropositivity relative to the flock size (P<0.001, linear regression). Therefore, larger flocks had a higher risk of sheep scab, which may be caused by more frequent animal movement. Spatial analysis of the results revealed a region with significantly higher risk (relative risk = 3.5, P<0.001) of seropositivity, where no cases have officially been notified in the period between 1997 and 1999. The next goal is to establish an efficient control strategy based on serological monitoring of the total sheep population.

Efficacy of ivermectin delivered via a controlled-release capsule against small lungworms (Protostrongylidae) in sheep

To evaluate the efficacy of an ivermectin controlled-release capsule (CRC), which delivers 1.6 mg ivermectin per day intraruminally for 100 days to sheep weighing 40-80 kg (IVOMEC Maximizer CR Capsule for adult sheep, Merial), against small lungworms two studies with 48 naturally infected adult female Merino Landrace sheep were conducted. The sheep were allocated by restricted randomization based on bodyweight to untreated controls or received an ivermectin CRC. Eight sheep per group were necropsied 35, 70 or 105 days post-treatment. Lungworms were recovered by dissection or peptic digestion of the lungs. Baermann/Wetzel technique was used for faecal lungworm larval counts at weekly intervals. The efficacy of treatment was 100% against Dictyocaulus filaria and Protostrongylus rufescens (P < 0.05) at each necropsy day. The efficacy against Protostrongylus brevispiculum, Cystocaulus ocreatus and Neostrongylus linearis increased from 35 to 105 days after administration of the CRC and was found to be 100% (P < 0.01), 96.6% (P < 0.01) or 99% (P < 0.01), respectively, at 105 days post-treatment. The reductions of Muellerius capillaris counts varied and were 96.2% (P < 0.05) at 70 days post-treatment and 44.6% (P > 0.1) at 105 days post-treatment. Faecal lungworm larvae disappeared nearly completely from at least 3 weeks after the ivermectin CRC administration for all protostrongylid species including M. capillaris so that pasture infectivity will be subsequently significantly reduced.

Effects of Psoroptes ovis infection and its control with an ivermectin controlled-release capsule on growing sheep. 2. Evaluation of wool production and leather value

To evaluate the prophylactic and therapeutic effects of an ivermectin controlled-release capsule (IVM-CRC) on the productivity of growing sheep infested with Psoroptes ovis 24 male and 24 female Merino landrace lambs, 5-6 months old and weighing 21.2-35.0 kg, were used. Sixteen replicates of three animals were formed based on sex and Day 0 body weight. Within each replicate animals were randomly allocated to one of three groups: untreated control; IVM-CRC on Day 0; IVM-CRC on Day 84. For treatment an IVM-CRC for sheep weighing 20-45 kg was used which is designed to deliver ivermectin at a minimum dose of 20 microg/kg/day for 100 days. The lambs were infested with 50-60 P. ovis mites each on days 14 and 21. The animals were shorn on Day 126. After slaughter on Day 127 the quality of the leather produced from their skins was evaluated. The IVM-CRC treatment on Day 0 prevented the establishment of P. ovis. All untreated lambs became infested. The lambs treated with an IVM-CRC on Day 84 became mite-free from Day 112 onwards. The lambs which were treated on Day 0 had significantly (p<0.05) greater clean fleece weight (1.5 kg) and fleece yield (52.1%) than the untreated controls (0.9 kg and 34.1%, respectively) or than lambs treated on Day 84 (1.0 kg and 47.8%, respectively). Clean fleece weight and fleece yield were in the tendency (p=0.055) or significantly (p<0. 001) greater, respectively, for lambs treated on Day 84 than for the untreated controls. The chrome tanned dried crust leather of all untreated controls and six of the 16 lambs treated on Day 84 showed grain surface defects such as discolourations, indurations and coarse, pitted grain. The useful (defect-free) leather size was significantly (p<0.01) higher for the lambs treated on Day 0 (100%) than for the lambs treated on Day 84 (82.7%) and the untreated controls (7.8%). The physical testing revealed that the leather of sheep treated on Day 0 had significantly (p<0.05) higher thickness, elongation break and tear resistance than the leather of both untreated controls and sheep treated on Day 84. There were no significant differences in the physical characteristics of the leather of the untreated controls and the sheep treated on Day 84.